Global Human Micobiome Market: key Vendors, Trends, Analysis, Segmentation, Forecast to 2018-2023

Press Release adds “Human Micobiome Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

This report provides in depth study of “Human Micobiome Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Human Micobiome Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

This report studies the global Human Micobiome market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Human Micobiome market by companies, region, type and end-use industry.

In 2017, the global Human Micobiome market size was 170 million US$ and it is expected to reach 820 million US$ by the end of 2025, with a CAGR of 21.7% during 2018-2025.

This report focuses on the global top players, covered
Seres Therapeutics
Second Genome
Enterome BioScience
4D Pharma Research Ltd
Ritter Pharmaceuticals
Symbiotix Biotherapies
MicroBiome Therapeutics LLC

Market segment by Regions/Countries, this report covers
United States
Southeast Asia

Market segment by Type, the product can be split into
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome

Market segment by Application, split into

Request a Sample Report @

Major Key Points in Table of Content

Global Human Micobiome Market Size, Status and Forecast 2025
1 Industry Overview of Human Micobiome
1.1 Human Micobiome Market Overview
1.1.1 Human Micobiome Product Scope
1.1.2 Market Status and Outlook
1.2 Global Human Micobiome Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Human Micobiome Market by Type
1.3.1 Gastrointestinal Tract Human Micobiome
1.3.2 Urogenital Tract Human Micobiome
1.3.3 Other
1.4 Human Micobiome Market by End Users/Application
1.4.1 Treatment
1.4.2 Diagnosis

2 Global Human Micobiome Competition Analysis by Players
2.1 Human Micobiome Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Vedanta
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.2 Seres Therapeutics
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.3 Second Genome
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.4 Rebiotix
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.5 ActoGeniX
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.6 Enterome BioScience
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.7 AvidBiotics
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.8 4D Pharma Research Ltd
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.9 Enterologics
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.10 Metabogen
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Human Micobiome Revenue (Million USD) (2013-2018)
3.11 Metabiomics
3.12 Ritter Pharmaceuticals
3.13 Osel
3.14 Symberix
3.15 Miomics
3.16 Symbiotix Biotherapies
3.17 MicroBiome Therapeutics LLC

4 Global Human Micobiome Market Size by Type and Application (2013-2018)
4.1 Global Human Micobiome Market Size by Type (2013-2018)
4.2 Global Human Micobiome Market Size by Application (2013-2018)
4.3 Potential Application of Human Micobiome in Future
4.4 Top Consumer/End Users of Human Micobiome


Contact Us: [email protected]

Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)